International Journal of Clinical Biochemistry and Research

Print ISSN: 2394-6369

Online ISSN: 2394-6377

CODEN : IJCBK6

International Journal of Clinical Biochemistry and Research (IJCBR) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award more...

  • Article highlights
  • Article tables
  • Article images

Article statistics

Viewed: 917

PDF Downloaded: 571


Get Permission Saloni: To study adrenal insufficiency and to determine relationship between BMI and serum cortisol levels in cirrhotic patients


Introduction

Relative adrenal insufficiency (RAI) is a syndrome characterized by decreased production of cortisol with respect to peripheral demands.1

Cortisol is a steroid hormone that regulates metabolism and immune system, maintenance of vascular tone and inhibition of production of proinflammatory cytokines and adhesion molecule expressions.2

Over 90% of circulating cortisol is bound to Corticosteroid binding globulin (CBG) (also called transcortin) and albumin, with less than 10% in the free biologically active form.3

To assess the severity of the liver disease, scoring models have been used. The oldest model is the Child-Pugh classification.4

A recent model has been developed for the assessment of prognosis which is the Model of End-stage Liver Disease (MELD) score.5 In this model there are only objective parameters, bilirubin, prothrombin time and creatinine. It is used to calculate mortality risk for patients with end-stage live r disease.6,7

The percentage of AI in cirrhotic patients varies among different studies and depends on different methods and criteria used to evaluate adrenal function.8

With SD-SST, the prevalence of AI in terminally ill cirrhotic patients varied between 10%9 to 87%10

With LD-SST, the prevalence of AI in terminally ill cirrhotic patients varied between 33%11 and 60%.12

Adrenal insufficiency (AI) has been described in all stages of cirrhotic patients.13 However, the exact mechanism leading to AI in cirrhotic population is not yet known. It is known that cholesterol is an important substrate for steroid synthesis and adrenal glands synthesize cortisol whenever is necessary. In cirrhosis, the adrenal glands synthesize the reduced amount of cortisol especially under stress conditions leading to “adrenal exhaustion syndrome” ending to AI.14

The mechanism of action of ACTH is through binding to a seven-membrane-spanning G protein-coupled ACTH receptor.15

Upon ligand binding, the receptor undergoes conformational changes that stimulate adenylyl cyclase, which further leads to an increase in intracellular cAMP and subsequent activation of protein kinase A. It stimulates lipoprotein uptake into cortical cells. This stimulates transcription of the genes coding for P450scc, steroid 11β-hydroxylase, and their associated electron transfer proteins.16

Aims and Objectives of the study

  1. To study adrenal insufficiency in patients of cirrhosis.

  2. To determine the relationship between BMI and serum cortisol levels.

Materials and Methods

Source of data

Patients admitted in medicine/gastroenterology ward of DMC&H

50 consecutive patients of cirrhosis were included in the study.

Inclusion criteria

Diagnosed patients of cirrhosis based on clinical/ biochemical / radiological/ endoscopy and or liver biopsy.

Exclusion criteria

  1. HIV/Immunodeficiency

  2. Severe chronic heart disease

  3. Chronic obstructive lung disease

  4. Chronic hemodialysis

  5. Severe sepsis or septic shock.

  6. Patients on steroid therapy

Depending upon the levels of cortisol, patients were divided into 3 groups:

Group I Patients having > 15 μg /dl cortisol (Baseline levels) n=31

Group II Patients having 3 -15 μg /dl cortisol (Baseline levels) n=11

Group III Patients having < 3 μg /dl cortisol (Baseline levels) n=8

In Group II, ACTH Stimulation (SD-SST) was done, then this Group was further divided into II a and II b

II a Patients having >18 μg /dl cortisol levels 30 minutes after ACTH stimulation (n=5)

II b Patients having <18 μg /dl cortisol levels 30 minutes after ACTH stimulation (n=6)

Diagnostic criteria for Adrenal Insufficiency

Levels of serum cortisol at 6-10 am <3µg/ dI confirms Adrenal Insufficiency.

Levels of serum cortisol at 6-10 am >15µg/ dI rules out Adrenal Insufficiency

Intermediate cortisol levels at 6-10 am are 3-15 µg/dl.

ACTH Stimulation were performed for intermediate cortisol levels. The diagnosis of adrenal insufficiency was considered if the serum cortisol level is <18µg/ dI, 30 minutes after stimulation.17

All the 50 patients were diagnosed on ultrasound findings.

Liver function tests were done in all the patients

Table 1
Factor Units 1 2 3
Serum bilirubin mg/dl 1-1.9 2-2.9 >3
Serum albumin g/dl >3.5 2.8-3.5 <2.8
Prothrombin time / INR Seconds 1-3 <1.7 4-6 1.7-2.3 >6 >2.3
Ascites absent Slight Moderate
Hepatic encephalopathy grade none 1&2 3&4

Child-Turcotte-Pugh scoring system

[i]

Group A- CTP Score (5-6)

MELD Score: Model for End-Stage Liver Disease.

3.8(loge serum bilirubin mg/dl) +11.2(loge INR) +9.6(loge serum creatinine mg/dl) +6.4.

Assay

Serum cortisol levels were determined by Electrochemiluminescence Immunoassay

Statistical analysis

The data was analyzed using Microsoft excel and SPSS version 20.0 (IBM SPSS, Chicago, Illinois). Mean and standard deviation were computed for the variables. The comparison between groups were done by Chi square and ANOVA. P value ≤ 0.005 was taken as significant.

Distribution of subjects according to adrenal function

Out of 50 patients included in this study, 14 (28%) patients had Adrenal Insufficiency

Table 2
BMI Group I Group II a Group II b Group III P value
<18.5 (n=3) 3 (9.67%) 0(0.00%) 0(0.00%) 0(0.00%) 0.007
18.5 -22.9 (n=10) 10 (32.25%) 0(0.00%) 0(0.00%) 0(0.00%)
23-24.9 (n=14) 7 (22.58%) 2(40.00%) 3(50.00%) 1(12.5%)
>25 (n=23) 11 (35.48%) 3(60.00%) 3(50.00%) 7(87.5%)
MEAN ± SD 23.87 ± 4.23 26.1 ± 2.78 26.41 ± 3.78 30.34 ± 6.4

Distribution of subjects according to BMI

Out of 50 patients enrolled, 37 patients had BMI > 23. All the Adrenal insufficient patients had BMI ≥ 23. All the patients with BMI< 23 were in Group I. A significant relationship was found between cortisol levels and BMI (p=0.007).

Figure 1
https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/ecc9a984-2a38-4e32-98d5-9b3368070a7a/image/31f290ed-f22d-40d5-a42f-6549a5249895-uimage.png

Discussion

The prevalence of AI in Cirrhosis was 28% in our study. Acevedo et al18 reported 26% AI. Galbois et al19 reported 33% AI prevalence whereas other studies reported higher prevalence of AI.20

Prevalence varies according to choice of subjects in different studies. Higher prevalence of AI was found in studies that included subjects with liver failure, liver transplant recipients and critically ill cirrhotic patients as compared to studies with stable cirrhotic patients. The percentage of AI in cirrhotic patients varies among different studies and depends on the different methods used to estimate adrenal function.

Out of 50 patients enrolled, 37 patients had BMI > 23. All the Adrenal insufficient patients had BMI ≥ 23. All the patients with BMI< 23 were in Group I. A significant relationship was found between cortisol levels and BMI (p=0.007).

Higher the BMI, lesser the value of serum cortisol. Therefore there was inverse relationship between serum cortisol levels and BMI.

A cause- effect relationship between obesity and cortisol levels is not clearly known, it may be either due to altered hypothalamic-pituitary-adrenal axis in obesity or due to enchanced metabolic clearance of cortisol in obesity.

Conclusion

We concluded that AI forms important part of spectrum of Chronic liver disease and these patients should be evaluated for adrenal dysfunction periodically.

Source of funding

None.

Conflict of interest

None.

References

1 

P Schuetz B Muller The hypothalamic-pituitary-adrenal axis in critical illnessEndocrinol Metab Clin North Am200635823838

2 

D Annane J M Cavaillon Corticosteroid in sepsis: from bench to bedside?Shock200320197207

3 

P M Stewart H M Kronenberg S Melmed K S Polonsky P R Larsen The adrenal cortex. In: Williams textbook of endocrinology. 11th ed445Saunders Philadelphia2008503

4 

R N Pugh I M Marray-Lyon J L Dawson M C Pietroni R Williams Transection of the oesophagus for bleeding oesophageal varicesBr J Surg197360646609

5 

P S Kamath R H Wiesner M Malinchoc W Kremers T M Therneau C L Kosberg A model to predict survival in patients with end-stage liver diseaseHepatol200133464470

6 

A Said J Williams J Holden P Remington R Gangnon A Musat Model for end-stage liver disease score predicts mortality across a broad spectrum of liver diseaseJ Hepatol200440897903

7 

P S Kamath W R Kim The model for end-stage liver disease (MELD)Hepatol200745797805

8 

G Fede L Spadaro T Tomaselli G Privitera S Piro A M Rabuazzo Assessment of adrenocortical reserve in stable patients with cirrhosisJ Hepatol201154243250

9 

T Thevenot S Borot A Remy-Martin R Sapin J P Cervoni C Richou Assessment of adrenal function in cirrhotic patients using concentration of serum-free and salivary cortisolLiver Int 201131425433

10 

M B Mohamed G Hamed A Heikal H Darwish Prevalence of adenocortical insufficiency in patients with liver cirrhosis, liver cirrhosis with septic shock and in patients with hepatorenal syndromeJ Am Sci 20117391400

11 

P E Marik T Gayowski T E Starzl The hepatoadrenal syndrome: a common yet unrecognized clinical conditionCrit Care Med 20053312541259

12 

C K Triantos M Marzigie G Fede M Michalaki D Giannakopoulou Critical illness-related corticosteroid insufficiency in patients with cirrhosis and variceal bleedingClin Gastroenterol Hepatol 20119595601

13 

T Tan L Chang A Woodward B McWhiney J Galligan G A Macdonald Characterizing adrenal function using directly measured plasma free cortisol in stable severe liver diseaseJ Hepatol 201053841848

14 

P E Mark Adrenal-exhaustion syndrome in patients with liver diseaseIntensive Care Med 200632275280

15 

M Raikhinstein M Zohar I Hanukoglu cDNA cloning and sequence analysis of the bovine adrenocorticotropic hormone (ACTH) receptorBiochimica Et Biophysica Acta199412203329323

16 

I Hanukoglu R Feuchtwanger A Hanukoglu Mechanism of corticotropin and cAMP induction of mitochondrial cytochrome P450 system enzymes in adrenal cortex cellsJ Biol Chem 1990265332060220608

17 

A G Loachimescu A H Hamrahian Diseases of Adrenal gland. In: Disease management Endocrinology Cleveland clinic Current clinical Medicine J Am Sci20104336349

18 

J Acevedo J Fernandez V Prado A Silva M Castro M Pavesi Relative adrenal insufficiency in decompensated cirrhosis: relationship to short-term risk of severe sepsis, hepatorenal syndrome, and deathHepatol20135817571765

19 

A Galbois M Rudler J Massard Y Fulla A Bennani D Bonnefont- Rousselot Assessment of adrenal function in cirrhotic patients: salivary cortisol should be preferredJ Hepatol201052839845

20 

R Harry G Auzinger J Wendon The effects of supraphysiological doses of corticosteroids in hypotensive liver failureLiver Int2003237177



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Article type

Original Article


Article page

518-521


Authors Details

Saloni


Article Metrics


View Article As

 


Downlaod Files